Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases susceptible to CIP,% cases susceptible to TET,% cases susceptible to CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"21,515 (9,693, 33,754)","59.6% (47.0%, 85.4%)","71.5% (53.6%, 84.0%)","17.5% (11.4%, 38.7%)","57.2% (44.8%, 83.1%)","20.9 (16.5, 29.9)","25.0 (18.8, 29.4)","6.1 (4.0, 13.5)","20.0 (15.7, 29.1)",,,,,
"(p=None, None), q=(None, None), c=0.500)","18,458 (8,783, 32,256)","68.1% (52.6%, 94.0%)","46.4% (30.9%, 71.0%)","10.0% (6.5%, 14.3%)","65.5% (50.0%, 92.4%)","23.8 (18.4, 32.9)","16.2 (10.8, 24.9)","3.5 (2.3, 5.0)","22.9 (17.5, 32.3)","-14.7% (-27.9%, -0.4%)","14.4% (3.9%, 25.1%)","-35.1% (-53.9%, -12.1%)","-38.4% (-74.3%, -9.9%)","14.8% (4.2%, 25.5%)"
"(p=None, None), q=(None, None), c=0.750)","18,482 (8,698, 31,404)","68.5% (52.2%, 95.6%)","45.8% (30.5%, 70.1%)","9.6% (6.2%, 14.2%)","66.2% (50.0%, 94.4%)","24.0 (18.3, 33.5)","16.0 (10.7, 24.5)","3.4 (2.2, 5.0)","23.2 (17.5, 33.0)","-14.4% (-27.5%, -2.2%)","15.3% (6.1%, 26.1%)","-36.0% (-53.3%, -13.6%)","-40.5% (-75.2%, -14.1%)","16.0% (6.3%, 27.2%)"
"(p=None, None), q=(None, None), c=1.000)","18,727 (8,605, 31,764)","68.7% (53.1%, 96.2%)","45.1% (29.6%, 68.2%)","9.3% (6.0%, 13.9%)","66.3% (50.7%, 95.2%)","24.0 (18.6, 33.7)","15.8 (10.4, 23.9)","3.2 (2.1, 4.9)","23.2 (17.7, 33.3)","-13.3% (-26.4%, -1.4%)","15.5% (6.3%, 26.7%)","-36.9% (-55.0%, -13.5%)","-42.8% (-74.6%, -17.3%)","16.2% (6.5%, 28.0%)"
